Most Recent
Construction PRO
Lendlease sells stake in Docklands development to Japanese real estate firm
Lendlease has sold a stake in a $500 million Melbourne build-to-rent development to Japanese real estate firm Tokyo Tatemono.
James Hardie to fight shareholder class action’s ‘new case’
James Hardie is fighting a bid to amend a shareholder class action over the building materials giant's 2023 income forecasts, telling the court it doesn't understand the “new case”.
Construction PRO
APA Group strikes deal with CS Energy over Brigalow Peaking power plant
Energy infrastructure firm APA Group has signed an agreement with CS Energy to jointly develop a 400 megawatt gas power station in southern Queensland.
Sun Pharma defeats appeal over Otsuka’s injectable Abilify patent
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.
Construction PRO
Realterm adds $89M to pipeline with two Sydney industrial assets
Global transport investment manager Realterm has acquired two logistics sites in Revesby and Ingleburn worth $89 million, expanding its Sydney portfolio to five assets. 
First Guardian CIO wants to sell Tucker, Gleeson paintings to pay lawyers
The receiver for a Falcon Capital fund under investigation by ASIC wants a role in selling director Simon Selimaj’s valuable artwork, including a $70,000 Albert Tucker painting, which is allegedly needed to cover legal fees. 
Meta says ACCC has ‘fundamental’ misunderstanding in scam ads case
Facebook owner Meta has argued the Australian Competition and Consumer Commission has “misallocated responsibility” in its three-year-old case over scam cryptocurrency ads on the social media platform.
ABA does about-face on diversity and inclusion committee
The peak body for barristers in Australia has reinstated its diversity and inclusion committee, after its chair posted on LinkedIn that the committee was being discontinued.
Regeneron, Bayer settle appeal over launch of Sandoz’s Eylea biosimilar
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea. 
Kids take fight over ‘unconstitutional’ social media ban to High Court
Two teenagers have brought a High Court challenge to the government's ban on children under 16 using social media, arguing that it is unconstitutional because of its burden the freedom of political communication.